The Quantification of Oxycodone and Its Phase I and II Metabolites in Urine

被引:2
作者
Truver, Michael T. [1 ]
Jakobsson, Gerd [1 ,2 ]
Cherma, Maria D. [2 ]
Swortwood, Madeleine J. [3 ]
Green, Henrik [1 ,2 ]
Kronstrand, Robert [1 ,2 ]
机构
[1] Linkoping Univ, Dept Biomed & Clin Sci, Fac Med, Div Drug Res, S-58183 Linkoping, Sweden
[2] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, S-58758 Linkoping, Sweden
[3] Sam Houston State Univ, Coll Criminal Justice, Dept Forens Sci, 1003 Bowers Blvd, Huntsville, TX 77340 USA
关键词
MAJOR METABOLITES; MASS-SPECTROMETRY; HUMAN PLASMA; NOROXYCODONE; OXYMORPHONE; QUANTITATION; PATTERNS; IDENTIFICATION; MORPHINE;
D O I
10.1093/jat/bkaa186
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The purpose of this research was to develop and validate an analytical method for the detection and quantification of noroxymorphone-3 beta-D-glucuronide (NOMG), oxymorphone-3 beta-D-glucuronide (NOMG), noroxymorphone (NOM), oxymorphone (OM), 6 alpha-oxycodol (alpha OCL), 6 beta-oxycodol (beta OCL), noroxycodone (NOC) and oxycodone (OC) in urine by liquid chromatography tandem mass spectrometry to be used in a human study. The method was validated according to the Academy Standards Board Standard Practices for Method Development in Forensic Toxicology. The method was then applied to a single-dose pilot study of a subject. Urine samples were collected from the subject after ingesting 10-mg OC as an immediate-release tablet. Additionally, urine specimens (n = 15) that had previously been confirmed positive for OC were analyzed using the validated method. The calibration range for NOMG and OMG was 0.05-10 mu g/mL; for all other analytes, it was 0.015-10 mu g/mL. Validation parameters such as bias, precision, carryover and dilution integrity, all met the validation criteria. After the method was validated, urine samples from the first subject in the controlled dose study were analyzed. It was observed that OC, NOC and OMG contained the highest concentrations and were present in either the 0.5 or 1 h void. NOC and OMG were detected until the 48 h collection, while OC was detectable till the 24 h collection. Time to reach maximum concentration (T-max) in the urine was achieved within 1.5 h for OC and within 3 h for NOC and OMG. Maximum concentration (C-max) in the urine for OC, NOC and OMG was 3.15, 2.0 and 1.56 mu g/mg, respectively. OC concentrations in authentic urines ranged from 0.015 to 12 mu g/mL. Ranges for NOMG and OMG were 0.054-9.7 mu g/mL and 0.14-67 mu g/mL, respectively. A comprehensive method for the quantification of NOMG, OMG, NOM, OM, alpha OCL, beta OCL, NOC and OC in urine was optimized and met the validation criteria. The concentrations of NOMG and OMG presented in this study provide the details needed in the forensic community to better comprehend OC pharmacokinetics.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 21 条
[1]  
American Academy of Forensic Science (AAFS) Standard Board (ASB), 2019, 036 AAFS ASB
[2]   Identification of new oxycodone metabolites in human urine by capillary electrophoresis-multiple-stage ion-trap mass spectrometry [J].
Baldacci, A ;
Caslavska, J ;
Wey, AB ;
Thormann, W .
JOURNAL OF CHROMATOGRAPHY A, 2004, 1051 (1-2) :273-282
[3]   Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS-MS [J].
Coles, Rebecka ;
Kushnir, Mark M. ;
Nelson, Gordon J. ;
McMillin, Gwendolyn A. ;
Urry, Francis M. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2007, 31 (01) :1-14
[4]   Prescription Opioids. I. Metabolism and Excretion Patterns of Oxycodone in Urine Following Controlled Single Dose Administration [J].
Cone, Edward J. ;
Heltsley, Rebecca ;
Black, David L. ;
Mitchell, John M. ;
LoDico, Charles P. ;
Flegel, Ronald R. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2013, 37 (05) :255-264
[5]   A rapid and sensitive high-performance liquid chromatography-electrospray ionization-triple quadrupole mass spectrometry method for the quantitation of oxycodone in human plasma [J].
Dawson, M ;
Fryirs, B ;
Kelly, T ;
Keegan, J ;
Mather, LE .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2002, 40 (01) :40-44
[6]   Improved Detection of Opioid Use in Chronic Pain Patients through Monitoring of Opioid Glucuronides in Urine [J].
Dickerson, Jane A. ;
Laha, Thomas J. ;
Pagano, Monica B. ;
O'Donnell, Brendan R. ;
Hoofnagle, Andrew N. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2012, 36 (08) :541-547
[7]   Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem [J].
Edwards, Stephen R. ;
Smith, Maree T. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 848 (02) :264-270
[8]   Determination of Oxycodone, Noroxycodone and Oxymorphone by High-Performance Liquid ChromatographyElectrospray Ionization-Tandem Mass Spectrometry in Human Matrices: In vivo and In vitro Applications [J].
Fang, Wenfang B. ;
Lofwall, Michelle R. ;
Walsh, Sharon L. ;
Moody, David E. .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2013, 37 (06) :337-344
[9]   Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry [J].
Gaudette, Fleur ;
Sirhan-Daneau, Andrea ;
St-Onge, Maude ;
Turgeon, Jacques ;
Michaud, Veronique .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2016, 1008 :174-180
[10]   Detection and quantification of codeine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, morphine 3-glucuronide and morphine-6-glucuronide in human hair from opioid users by LC-MS-MS [J].
Grabenauer, Megan ;
Bynum, Nichole D. ;
Moore, Katherine N. ;
White, Robert M. ;
Mitchell, John M. ;
Hayes, Eugene D. ;
Flegel, Ronald .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2018, 42 (02) :115-125